STOCK TITAN

Imunon (IMNN) CEO awarded 67,150 shares instead of cash bonus

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. President and CEO Stacy Lindborg reported a stock-based compensation grant on Common Stock. She was awarded 67,150 shares at $1.72 per share as stock granted in lieu of cash for 50% of her 2025 annual cash bonus. Following this grant, she directly holds 74,188 shares of Common Stock. She also has an indirect holding of 778 shares through a 401(k) plan, which reflects plan holdings rather than a new market transaction.

Positive

  • None.

Negative

  • None.
Insider Lindborg Stacy
Role President and CEO
Type Security Shares Price Value
Grant/Award Common Stock 67,150 $1.72 $115K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 74,188 shares (Direct, null); Common Stock — 778 shares (Indirect, By 401(k) Plan)
Footnotes (1)
  1. [object Object]
Stock grant shares 67,150 shares Common Stock granted as part of 2025 annual bonus
Grant price $1.72 per share Price per share for the 67,150-share award
Direct holdings after grant 74,188 shares Direct Common Stock owned by Stacy Lindborg after transaction
Indirect 401(k) holdings 778 shares Common Stock held indirectly via 401(k) plan
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
401(k) Plan financial
"nature_of_ownership: By 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
annual cash bonus financial
"Stock granted in lieu of cash for 50% of 2025 annual cash bonus"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lindborg Stacy

(Last)(First)(Middle)
C/O IMUNON, INC.
997 LENOX DRIVE, SUITE 100

(Street)
LAWRENCEVILLE NEW JERSEY 08648

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/25/2026A67,150(1)A$1.7274,188D
Common Stock778IBy 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Stock granted in lieu of cash for 50% of 2025 annual cash bonus
/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg06/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Imunon (IMNN) CEO Stacy Lindborg report?

Stacy Lindborg reported receiving a stock grant of Common Stock. She was awarded 67,150 shares at $1.72 per share as compensation, replacing 50% of her 2025 annual cash bonus with equity instead of cash.

How many Imunon (IMNN) shares was the CEO granted and at what price?

The CEO was granted 67,150 shares of Imunon Common Stock at $1.72 per share. This award is described as stock granted in lieu of cash for 50% of her 2025 annual cash bonus, making it a compensation-related equity grant.

What are Stacy Lindborg’s Imunon (IMNN) share holdings after this Form 4?

After the reported grant, Stacy Lindborg directly owns 74,188 shares of Imunon Common Stock. She also has an additional 778 shares held indirectly through a 401(k) plan, which reflects retirement-plan holdings rather than a separate open-market trade.

Is the Imunon (IMNN) CEO’s Form 4 transaction an open-market purchase or sale?

The Form 4 shows a grant or award acquisition, not an open-market trade. Shares were granted as stock in lieu of cash for part of her 2025 annual bonus, so it is compensation-related rather than a discretionary market purchase or sale.

How is the Imunon (IMNN) CEO’s 401(k) holding reflected in this Form 4?

The filing shows 778 Imunon shares held indirectly through a 401(k) plan. This entry is categorized as a holding rather than a new buy or sell transaction, indicating the retirement-plan position rather than a fresh market trade on the transaction date.